Therapy News and Research

RSS

Stress and depression help explain intertwined alcohol, sleep problems

Insomnia and hazardous drinking are so closely intertwined that estimates suggest at least one-third, and as many as 91%, of people who have a hard time with sleep also misuse alcohol.

14 Apr 2025

Gut imbalances in autism linked to brain and behavior changes

A new USC study suggests that gut imbalances in children with autism may create an imbalance of metabolites in the digestive system - ultimately disrupting neurotransmitter production and influencing behavioral symptoms.

14 Apr 2025

Northwestern scientists identify key genes behind Parkinson's development

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also carry such variants do not.

11 Apr 2025

UVA researcher wins major grant to revolutionize breast cancer treatment

A promising approach to achieve safer, more effective, and more precise breast cancer treatment has earned a University of Virginia researcher a new $5.5 million grant.

11 Apr 2025

Boosting tumor-infiltrating lymphocyte therapy with the power of B cells

Researchers at Moffitt Cancer Center have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL therapy.

11 Apr 2025

COVID-19 treatments show minimal serious side effects

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an excessive immune response.

11 Apr 2025

GSK3β identified as a driver of drug resistance in BRAF mutant melanoma

A new research perspective was published in Oncotarget, Volume 16, on April 4, 2025, titled "GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells."

11 Apr 2025

Police officers at higher risk of traumatic brain injuries and PTSD

Police officers are more than twice as likely to have traumatic brain injuries compared to the general population. Officers who incur these injuries while on duty face more than double the risk of developing complex post-traumatic stress disorder (PTSD).

11 Apr 2025

New guidelines released for managing hypercholesterolemia in adults over 75

The National Lipid Association (NLA) and the American Geriatrics Society (AGS) have released a Joint Scientific Statement focused on the management of hypercholesterolemia in adults older than 75 years who do not have a history of atherosclerotic cardiovascular disease (ASCVD).

10 Apr 2025

Surface light chain expression in B-ALL after myeloma treatment: A unique case report

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence.

10 Apr 2025

Fecal microbiota transplantation emerges as a promising approach to H. pylori eradication

FMT is a novel therapeutic approach that involves transferring microbiota from a healthy donor to a patient's gastrointestinal tract.

10 Apr 2025

Understanding key risk factors behind shoulder injuries in athletes and aging adults

Shoulders are, in many ways, a marvel. One shoulder has four separate joints, packed with muscles, that allow us to move our arm in eight different major ways, giving us the most degrees of freedom of any joint in the body.

10 Apr 2025

Can psychedelics break compulsive eating habits in obesity?

A review by Oxford researchers explores how psychedelics like psilocybin and LSD may help disrupt compulsive eating behaviors in subsets of obese individuals. The paper outlines proposed neurobiological, epigenetic, and gut-brain mechanisms while emphasizing the need for human trials.

10 Apr 2025

WHO releases first global guidelines to improve meningitis care

The World Health Organization (WHO) has today published its first-ever global guidelines for meningitis diagnosis, treatment and care, aiming to speed up detection, ensure timely treatment, and improve long-term care for those affected.

10 Apr 2025

Mindfulness and cognitive behavioral therapies offer lasting relief for chronic low back pain

Researchers compare the long-term effectiveness of mindfulness and CBT among adults with opioid-treated chronic low back pain.

10 Apr 2025

Study overcomes chemotherapy limitations with lipid nanoparticles

Announcing a new article publication for the BIO Integration journal. Lipid-based Nanoparticles (LBNPs) have emerged as a transformative approach in cancer treatment, offering innovative drug delivery solutions that enhance therapeutic efficacy while minimizing adverse effects.

10 Apr 2025

Exophiala pneumonia identified in immunocompetent woman with lung disease

Exophiala, a genus of saprotrophic black fungi commonly found in the environment, is typically associated with cutaneous infections in immunocompromised hosts and rarely manifests as pneumonia.

9 Apr 2025

Sylvester Cancer Center launches clinical trial for patients with high-grade neuroendocrine tumors

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

9 Apr 2025

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions.

9 Apr 2025

Study shows minimal lean muscle mass loss with GLP-1 and GLP-1/GIP therapy for weight loss

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss experienced minimal lean muscle mass loss as they lost weight across 6 months of treatment.

9 Apr 2025

Therapy News and Research

Stress and depression help explain intertwined alcohol, sleep problems

Gut imbalances in autism linked to brain and behavior changes

Northwestern scientists identify key genes behind Parkinson's development

UVA researcher wins major grant to revolutionize breast cancer treatment

Boosting tumor-infiltrating lymphocyte therapy with the power of B cells

COVID-19 treatments show minimal serious side effects

GSK3β identified as a driver of drug resistance in BRAF mutant melanoma

Police officers at higher risk of traumatic brain injuries and PTSD

New guidelines released for managing hypercholesterolemia in adults over 75

Surface light chain expression in B-ALL after myeloma treatment: A unique case report

Fecal microbiota transplantation emerges as a promising approach to H. pylori eradication

Understanding key risk factors behind shoulder injuries in athletes and aging adults

Can psychedelics break compulsive eating habits in obesity?

WHO releases first global guidelines to improve meningitis care

Mindfulness and cognitive behavioral therapies offer lasting relief for chronic low back pain

Study overcomes chemotherapy limitations with lipid nanoparticles

Exophiala pneumonia identified in immunocompetent woman with lung disease

Sylvester Cancer Center launches clinical trial for patients with high-grade neuroendocrine tumors

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Study shows minimal lean muscle mass loss with GLP-1 and GLP-1/GIP therapy for weight loss

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News